What future directions are researchers exploring for hyperactivity in ADHD?

PostedAugust 25, 2025

UpdatedSeptember 5, 2025

ByMy Patient Advice

Author: Victoria Rowe, MSc | Reviewed by: Dr. Rebecca Fernandez, MBBS

Researchers are actively investigating new approaches to better understand and treat hyperactivity in ADHD. This evolving innovation roadmap is driven by emerging technologies, deeper biological insights, and a focus on personalised care.

By defining key scientific priorities and concentrating on ADHD focus areas, the research community aims to develop more effective, targeted, and holistic interventions in the years ahead.

Future Research Directions for ADHD Hyperactivity

Here are some promising paths that researchers are pursuing:

Genetic and Biological Insights

Uncovering the genetic and molecular underpinnings of hyperactivity in ADHD remains a top priority, with the hope of identifying new therapeutic targets.

Neuroimaging Advances

Improved brain imaging techniques are helping map the neural circuits involved in hyperactivity, offering a clearer understanding of its origins.

Personalised Treatments

Ongoing work in personalised medicine including genetic testing and individualised care plans is a major ADHD focus area.

Digital and AI-driven Tools

Researchers are exploring how digital therapeutics, apps, and artificial intelligence can monitor symptoms and deliver tailored interventions in real time.

Environmental and Lifestyle Research

Understanding how diet, sleep, exercise, and social environment interact with hyperactivity is shaping more holistic treatment strategies.

This innovation roadmap, built around clear scientific priorities, promises to refine how we address hyperactivity in ADHD. Visit providers like ADHD Certify for personal consultations and to learn how future research might benefit you.

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Hyperactivity.

Victoria Rowe, MSc

Author

Victoria Rowe is a health psychologist with a Master’s in Health Psychology and a BS in Applied Psychology. She has experience as a school psychologist, conducting behavioural assessments, developing individualized education plans (IEPs), and supporting children’s mental health. Dr. Rowe has contributed to peer-reviewed research on mental health, including studies on anxiety disorders and the impact of COVID-19 on healthcare systems. Skilled in SPSS, Minitab, and academic writing, she is committed to advancing psychological knowledge and promoting well-being through evidence-based practice.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.

Dr. Rebecca Fernandez, MBBS

Reviewer

Dr. Rebecca Fernandez is a UK-trained physician with an MBBS and experience in general surgery, cardiology, internal medicine, gynecology, intensive care, and emergency medicine. She has managed critically ill patients, stabilised acute trauma cases, and provided comprehensive inpatient and outpatient care. In psychiatry, Dr. Fernandez has worked with psychotic, mood, anxiety, and substance use disorders, applying evidence-based approaches such as CBT, ACT, and mindfulness-based therapies. Her skills span patient assessment, treatment planning, and the integration of digital health solutions to support mental well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewer's privacy.